Pharma Trend Germany
Pharma Trend is the survey of innovation and sustainability in pharmaceutical companies. The survey is representative, independent, and has been carried out by doctors in Germany annually since the year 2000.
For the survey, 100 doctors per specialist group were asked by Pharma Trend for their opinions. It appears that this sampling method is sufficient, as the results begin to stabilize as of around 80 respondents. The Pharma Trend survey is quantitative, specific to each discipline and, since 2014, has been carried out exclusively online. The market research institute Harris Interactive was tasked with carrying out the market research. The secured questionnaire is standardized to allow comparison of the survey results between years and between participating countries.
The Pharma Trend survey is carried out within particular disciplines chosen through market research, and is limited to 10 disciplines per year. The number of requests for each discipline decides how the research will be undertaken.
The Pharma Trend can be applied in Germany to all specialists without benchmarking (basic) or to specific fields of study with benchmarking (standard). The collection of discipline-specific sections of the report also contains the overall results across all fields.
The basic edition of Pharma Trend includes general information about the winner of “The Golden Tablet” award and “most innovative product”, with the reasons the titles were awarded, as well as ratings of company image and field work, some of which including year-on-year comparisons, and the “Pharma Trend® Best Pharmaceutical Companies” ranking. The standard edition of Pharma Trend Germany presents the data specific to fields of study as well as the benchmarked data.
Pharma Trend Europe Big 5
In 2003, the first Pharma Trend survey was carried out in France, Germany, Italy, Spain and the UK (the Big 5). The 3rd European survey is planned for 2018. The basis for the survey is the Pharma Trend questionnaire, which has been conducted in Germany under secure conditions for many years. The survey is carried out in specialty areas that pharmaceutical companies consider to be the most important. 100 doctors are surveyed per discipline and per country.
Pharma Trend Europe Big 5 contains country-specific analysis, with both general data and discipline-specific benchmarked data. When ordering Pharma Trend, the pharmaceutical company is included in the benchmark for its specialty.
Pharma Trend Europe Big 5 will decide the winners of the discipline-specific awards, “The Golden Tablet” and “Most Innovative Product”. In order to display these accolades, winners are entitled to country-specific emblems which indicate the relevant discipline. Additionally, a “Pharma Trend Most reputable Pharma Companies” ranking will be created for each individual country.
Specialist groups in Pharma Trend
Since the beginning of the Pharma Trend Germany survey in 2000, doctors in 14 disciplines have been surveyed: general practitioners & internists, dermatologists, diabetologists, gastroenterologists, gynecologists, otolaryngologists, cardiologists, neurologists & psychiatrists, oncologists, ophthalmologists, orthopedists / rheumatologists (OR), pediatricians, pneumologists and urologists. Pharma Trend focuses on the disciplines that provide treatment and prevention of the most common symptoms of illness: heart/circulatory problems, diabetes, central nervous system issues, oncology, and infection.
The Pharma Trend Europe Big 5 survey is planned for the following specialists:
- General Practitioners (GPs)
- neurologists & psychiatrists
Pharma Trend OTC
The Pharma Trend survey is also planned for OTC drugs as an 11th category in Germany in 2018. The target group for the survey are pharmacists.
The PharmaTrend OTC survey identifies the most innovative products in a category and deterrmines the winner of the award „Most Innovative Product”. By ordering the PharmaTrend OTC for a category, the respective pharmaceutical company is placed in the benchmark for the ranking “Pharma Trend® OTC Best Pharmaceutical Companies” and participates in the determination of the most innovative product of a category.